Valneva SE (INRLF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
23.30+0.95 (+4.25%)
At close: 3:08PM EDT
| Previous close | 22.35 |
| Open | 23.10 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 23.10 - 23.88 |
| 52-week range | 5.75 - 28.25 |
| Volume | 3,218 |
| Avg. volume | 6,350 |
| Market cap | 2.325B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.58 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Biotech Stock Roundup: BIIB's Q3 Earnings, REGN's COVID-19 Cocktail Update & More
Regulatory and pipeline updates from bigwigs like Regeneron (REGN) and Biogen (BIIB) have been the biotech sector's few key highlights during the past week.
- Zacks
Valneva (VALN) Reports Positive Data From COVID Vaccine Study
Valneva's (VALN) shares surge after its COVID vaccine demonstrates superiority over AstraZeneca's COVID vaccine in a phase III study.
- Motley Fool
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.
© 2021 Verizon Media. All rights reserved.
